Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 18Sarcoma 3Lymphoid 2Gynecologic 2Dermatologic 2Breast 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 22Lung Neoplasms 11Ovarian Neoplasms 10Breast Neoplasms 9Pancreatic Neoplasms 7Colorectal Neoplasms 7Stomach Neoplasms 6Melanoma 6Neoplasm Metastasis 5Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Mesothelioma, Malignant 4Urogenital Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Colonic Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma, Renal Cell 3Carcinoma, Merkel Cell 3Pleural Effusion, Malignant 2Liver Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Carcinoma, Adenosquamous 2Adenocarcinoma of Lung 2Adenocarcinoma 2

Interventions

Cyclophosphamide 2molibresib 1fludarabine 1aldesleukin 1Thalidomide 1Nivolumab 1LY2940680 1Interleukin-2 1Immunologic Techniques 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × aldesleukin × Thoracic × Clear all
NCT05296564 2025-10-02

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

Hadassah Medical Organization

Phase 1/2 Recruiting
3 enrolled
BreastCNSDermatologicGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasm Metastasis, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Sarcoma, Synovial, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡